Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells

Scientists developed a strategy to improve the efficiency of the iPSC gene editing process via application of a small-molecule, trichostatin A , a Class I and II histone deacetylase inhibitor.
[CRISPR Journal]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News